Original Research
Accepted on 26 Aug 2025
Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation
in Hematology
- 169 views